Bulk NMN, NAD+ (Nicotinamide Adenine Dinucleotide) for Cellular Longevity

NAD+ Overview

Nicotinamide adenine dinucleotide (NAD+, CAS 53-84-9, molecular formula C21H27N7O14P2, molecular weight 663.43 g/mol) is a central cellular coenzyme that shuttles electrons in redox metabolism and serves as the substrate for sirtuin and PARP enzyme families. The oxidized beta form of the dinucleotide is the reference identity indexed by PubChem (CID 5892), and it is the species most widely discussed in the healthy-aging, cellular-energy, and cognitive-support categories of the dietary supplement industry. In cellular biochemistry, NAD+ alternates with its reduced partner NADH to carry reducing equivalents through glycolysis, the Krebs cycle, and oxidative phosphorylation.

Purecium supplies food-grade NAD+ bulk powder in two commercial grades: a standard high-purity crystalline grade for capsules, tablets, and sachets, and a liposomal-grade NAD+ powder that is processed and characterized for compatibility with liposomal encapsulation systems. Production follows enzymatic synthesis from high-purity precursors rather than extraction from yeast biomass, giving formulation teams a reproducible oxidized coenzyme with documented identity, tight assay values, and a clean, consistent impurity profile across production lots. Both grades are qualified under one vendor program, which simplifies supplier audits and specification management for buyers, and grade-comparison data are shared so dosage weight and label positioning can be planned before scale-up.

Source & Ingredient Identity

In the dietary supplement raw-material market, NAD+ sits inside a wider family of related nicotinamide molecules, and buyers routinely compare these molecules when designing energy and longevity products. NADH is the reduced form of the same dinucleotide and carries the electron pair in metabolic cycles; NMN (nicotinamide mononucleotide, C11H15N2O8P) is a direct biosynthetic precursor of NAD+; and NR (nicotinamide riboside) is a further precursor that enters the salvage pathway before conversion to the coenzyme. Each family member has a distinct oxidation state, molecular weight, and stability profile, so each is qualified, labeled, and documented under its own specification rather than sold interchangeably.

The identity of Purecium NAD+ is anchored by the CAS registry number 53-84-9, the molecular formula C21H27N7O14P2, and the molecular weight 663.43 g/mol for the oxidized beta-nicotinamide adenine dinucleotide. Source material is produced by enzymatic synthesis from high-purity nicotinamide and nucleotide precursors, a route selected for its selectivity toward the biologically active beta anomer and for the absence of harsh chemical reagents. Finished powder is released in standard and liposomal grades under quality frameworks aligned with USP-NF and the European Pharmacopoeia for food and supplement ingredients, and identity is confirmed by chromatographic and spectroscopic methods before release.

Key Characteristics of NAD+

NAD+ bulk powder is a white to off-white crystalline solid that combines the characteristics formulators expect from a premium nucleotide raw material: high assay purity confirmed by HPLC, residual solvents within specification, and controlled heavy metals with lead below 0.5 ppm, arsenic below 3 ppm, cadmium below 1 ppm, and mercury below 0.1 ppm measured on every production lot. The standard grade flows reliably in capsule and tablet processing, while the liposomal-grade material is milled and characterized for liposomal delivery systems in which the sensitive coenzyme is protected from moisture and oxidation during encapsulation. Both grades ship with the same identity documentation and retained-sample program.

Functionally, NAD+ is the oxidized coenzyme at the center of cellular redox balance: it accepts electrons in catabolic reactions, regenerates NADH, and serves as the consumed substrate for sirtuin and PARP enzyme families that are central to research on cellular energy and aging biology. Because nucleotides are hygroscopic and sensitive to light, the powder is dried to a tight moisture specification and packed under low-humidity, light-protected conditions, and users are advised to keep sealed drums below 25°C in dry storage away from sunlight. Handling characteristics, moisture limits, and photostability notes are documented in the stability file that accompanies qualification packages and follows the general stability principles of the European Pharmacopoeia.

NAD+ Manufacturing

NAD+ is manufactured through a controlled enzymatic synthesis route that starts from high-purity nicotinamide and nucleotide precursors rather than from chemical condensation routes. Biocatalytic conversion, run under cGMP conditions, assembles the oxidized dinucleotide with high selectivity, and the product is then purified by chromatography and crystallization to remove residual substrates, related nucleotides, and process impurities. The enzymatic route is favored for NAD+ because it preserves the beta configuration of the glycosidic bond that defines biologically active beta-nicotinamide adenine dinucleotide, and it keeps the profile of related substances narrow and reproducible from lot to lot.

After purification, crystalline NAD+ is dried under vacuum to a controlled moisture endpoint, milled to the particle-size target of the selected grade, and blended for homogeneity before packing under low-humidity, nitrogen-flushed conditions in line with FDA current good manufacturing practice expectations for dietary ingredients. Stability programs cover a standard 24-month shelf life, and real-time plus accelerated data are available to support registration dossiers in regulated markets, with hydrolysis-related nicotinamide and other degradation products monitored as part of the related-substance panel. In-process and finished controls at each unit operation keep batch-to-batch consistency within the tight ranges required by premium finished-product brands.

Applications of NAD+

NAD+ is used by supplement brands and contract manufacturers in four primary application clusters. First, cellular-energy and longevity formulas, in which NAD+ acts as the substrate for sirtuins and PARPs and is examined in peer-reviewed biology research on cellular energy and aging. Second, NAD+ precursor stacks, in which NMN and NR appear alongside NAD+ because both are biosynthetic precursors that have been shown to raise NAD+ levels in research models. Third, cognitive and neuroprotection contexts, where NAD+ metabolism is studied for its role in neuronal energy homeostasis in NIH-indexed literature. Fourth, sports and recovery formulas that build on the redox-coenzyme function of NAD+ in muscle metabolism investigated in sports science.

In practice, brands formulate NAD+ as a finished ingredient in its own right or use it as the oxidized reference point inside precursor-stacking formulas that pair NAD+ with NMN and NR to cover multiple entry points of the biosynthesis and salvage pathways. Regulatory and scientific reference points are drawn from institutional sources rather than commercial claims: the redox function of the coenzyme is standard content in biochemistry reference frameworks, and peer-reviewed research has examined NAD+ metabolism in the contexts of aging, neuronal function, and cellular energetics in experimental models. Purecium supports customers with formulation guidance, stability data, and application testing for capsules, tablets, sachets, and beverage premixes.

Manufacturing & Quality Control

Every commercial batch of NAD+ is produced under ISO 9001 and FSSC22000 certified quality management systems in cGMP-compliant facilities with HACCP controls. Finished-product testing covers HPLC assay, related-substance analysis for nicotinamide and other nucleotides, loss on drying, heavy metals within USP limits, residual solvents tested per current USP procedures, and a full microbiological panel including total plate count, yeast and mold, and pathogen screening. Each shipment is released with a Certificate of Analysis (CoA) documenting every measured parameter, and analytical methods follow the current USP-NF and European Pharmacopoeia frameworks where applicable, with AOAC-referenced procedures used for supporting analyses.

Documentation accompanying every order includes the Safety Data Sheet (SDS), allergen statement, non-GMO verification, and BSE/TSE-free certification, with Kosher and Halal certificates supporting distribution into religious-market segments. End-to-end batch traceability lets customer quality teams audit precursor sourcing, enzymatic conversion parameters, purification steps, and final packing, and stability documentation that specifically covers the moisture and light sensitivity of the nucleotide is supplied on request. Regulatory support files and method validation summaries are provided to streamline finished-product registration with national authorities.

NAD+ for B2B Supplement Manufacturing

Purecium serves dietary supplement distributors, contract manufacturers (OEM/ODM), and terminal brand owners with bulk NAD+ standard-grade and liposomal-grade powder at a standard MOQ of 25 kg, packed in 25 kg net food-grade fiber drums with double polyethylene liners. Logistics options include air freight, ocean container loads (FCL/LCL), and expedited courier dispatch, with warehousing support in the United States for rapid restocking of North American production lines and direct export from China for EU, UK, and global customers. Packaging can be adjusted to project-specific requirements under the commercial agreement.

Commercial partners receive tiered volume pricing, pilot-scale samples for R&D evaluation, grade-selection guidance for liposomal versus standard formats, and proactive market intelligence on NAD-family raw-material trends. Purecium maintains over 15 years of nutraceutical export experience and a dedicated B2B account-management team that coordinates COA documentation, customs paperwork, and regulatory dossiers aligned with EFSA, FDA, and national-authority submission expectations to keep launch timelines on schedule. Reviewed by the Chief Quality Assurance / Regulatory Affairs Specialist at Purecium for technical accuracy and regulatory alignment.

How does Nad compare with NMN, NR, and NADH as a bulk ingredient for B2B formulation?
Nad (nicotinamide adenine dinucleotide, CAS 53-84-9) is a dinucleotide available as a bulk powder. NMN (nicotinamide mononucleotide, CAS 1094-61-7) and NR (nicotinamide riboside, CAS 1341-23-7) are mononucleotides, while NADH (reduced NAD, CAS 58-68-4) is the reduced form. All are hygroscopic and sensitive to moisture, heat, and pH extremes. Nad and NADH are chemically less stable than NMN and NR, requiring tighter storage controls. Typical doses in clinical and preclinical studies vary: Nad 100–500 mg/day, NMN 250–1000 mg/day, NR 300–1000 mg/day, and NADH 5–50 mg/day. For bulk formulation, Nad and NADH are usually dosed lower due to cost and stability, while NMN and NR are used at higher levels. Solubility in water is good for all, but NADH is less stable in solution and may require stabilizers or lyophilization. Regulatory status differs by region. In the US, NMN and NR are sold as dietary ingredients, though NMN’s status has been questioned by FDA. Nad and NADH are also marketed as dietary ingredients. In the EU, NMN and NR are not authorized novel foods, while Nad and NADH may require novel food evaluation. Bulk suppliers should provide documentation: CoA, MSDS, and stability data. Nad is typically supplied as a white to off-white powder, while NMN and NR are often crystalline powders. NADH is often supplied as a stabilized form (e.g., with sodium bicarbonate). Handling: all require cool, dry storage, protected from light. Nad and NADH are more prone to degradation; use desiccants and nitrogen flushing. For B2B, specify assay (e.g., ≥95% HPLC), heavy metals, microbial limits, and residual solvents. Documentation should include CAS, molecular formula, and purity profile. This comparison aids formulation decisions but requires verification against current regulations and supplier specifications.

Comparison in table form.
The table below sets out the parameters that determine how each material is specified, dosed and documented in a finished formulation.